Brainreader

Brainreader is a life science and healthcare technology company established in 2011. It specializes in advanced brain volumetrics through its flagship product, Neuroreader®, an FDA-cleared and CE-marked medical device. Neuroreader® automates the analysis of MRI brain scans, quantifying 45 critical brain structures in approximately 10 minutes. This software aids healthcare professionals in detecting acute abnormalities and neurodegenerative diseases, allowing for quicker prioritization of urgent cases and improved patient care. Neuroreader® employs intelligent algorithms to automate the segmentation and volumetric assessment of brain structures, producing detailed reports that assist in early diagnosis and monitoring of conditions such as Alzheimer's dementia and traumatic brain injury. The software is HIPAA compliant and is utilized in both clinical and research settings across the U.S. It integrates seamlessly into clinical workflows, providing objective and quantitative evaluations of MRI findings, which enhances clinical decision-making and supports healthcare professionals in their practice.

• Employees 7
• Founded 2011
• Annual Revenue $2500000
• Total Funding $7300000